These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 33798117

  • 21. Stability of Metronidazole Suspensions.
    Donnelly RF, Ying J.
    Int J Pharm Compd; 2015; 19(3):248-51. PubMed ID: 26714365
    [Abstract] [Full Text] [Related]

  • 22. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y, Chin ZW, Ellis D, Lwin EMP, Turner S, Williams D, Garg S.
    Am J Health Syst Pharm; 2018 Mar 01; 75(5):309-315. PubMed ID: 29472513
    [Abstract] [Full Text] [Related]

  • 23. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K, Hutchinson DJ, Chablani L.
    Am J Health Syst Pharm; 2018 May 01; 75(9):e236-e240. PubMed ID: 29691267
    [Abstract] [Full Text] [Related]

  • 24. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ, Johnson CE, Klein KC.
    Am J Health Syst Pharm; 2009 Apr 01; 66(7):665-7. PubMed ID: 19299374
    [Abstract] [Full Text] [Related]

  • 25. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
    Foley L, Toney J, Barlow JW, O'Connor M, Fitzgerald-Hughes D, Ramtoola Z.
    Molecules; 2021 Jan 08; 26(2):. PubMed ID: 33435555
    [Abstract] [Full Text] [Related]

  • 26. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE, Hart SM.
    Am J Hosp Pharm; 1993 Nov 08; 50(11):2353-5. PubMed ID: 8266961
    [Abstract] [Full Text] [Related]

  • 27. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV, Wei B, Liang D.
    Am J Health Syst Pharm; 2009 Jun 15; 66(12):1105-9. PubMed ID: 19498126
    [Abstract] [Full Text] [Related]

  • 28. Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF.
    Friciu M, Cull E, Leclair G.
    Int J Pharm Compd; 2024 Jun 15; 28(5):408-412. PubMed ID: 39405569
    [Abstract] [Full Text] [Related]

  • 29. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
    Cober MP, Johnson CE.
    Am J Health Syst Pharm; 2007 Mar 15; 64(6):644-6. PubMed ID: 17353574
    [Abstract] [Full Text] [Related]

  • 30. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D, Lin SW, Brown H, Sangaroomthong A, Shin D, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z.
    Int J Pharm Compd; 2018 Mar 15; 22(2):164-171. PubMed ID: 29877863
    [Abstract] [Full Text] [Related]

  • 31. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL, Johnson CE, Jacobson P.
    Am J Hosp Pharm; 1994 Oct 01; 51(19):2409-11. PubMed ID: 7847406
    [Abstract] [Full Text] [Related]

  • 32. The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
    Meissner S, Bansal M, Dela CPD, Hanning S, Svirskis D.
    Int J Pharm Compd; 2020 Oct 01; 24(2):140-147. PubMed ID: 32196476
    [Abstract] [Full Text] [Related]

  • 33. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV, Erickson MA.
    Am J Health Syst Pharm; 1996 Sep 01; 53(17):2073-8. PubMed ID: 8870895
    [Abstract] [Full Text] [Related]

  • 34. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE, Nesbitt J.
    Am J Health Syst Pharm; 1995 Aug 15; 52(16):1798-1800. PubMed ID: 8528836
    [Abstract] [Full Text] [Related]

  • 35. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
    Caruthers RL, Johnson CE.
    Am J Health Syst Pharm; 2007 Jul 15; 64(14):1513-5. PubMed ID: 17617502
    [Abstract] [Full Text] [Related]

  • 36. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP, Johnson CE, Sudekum D, Penprase K.
    Am J Health Syst Pharm; 2011 May 01; 68(9):843-5. PubMed ID: 21515869
    [Abstract] [Full Text] [Related]

  • 37. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS, Haribhakti RP, Parker GA.
    Am J Hosp Pharm; 1991 Jun 01; 48(6):1241-4. PubMed ID: 1858804
    [Abstract] [Full Text] [Related]

  • 38. Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes.
    St-Jean I, Friciu MM, Monfort A, MacMahon J, Forest JM, Walker S, Leclair G.
    Can J Hosp Pharm; 2021 Jun 01; 74(4):327-333. PubMed ID: 34602620
    [Abstract] [Full Text] [Related]

  • 39. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML, Johnson CE.
    Am J Hosp Pharm; 1992 Jan 01; 49(1):122-5. PubMed ID: 1570852
    [Abstract] [Full Text] [Related]

  • 40. Stability of an extemporaneous alcohol-free melatonin suspension.
    Johnson CE, Cober MP, Thome T, Rouse E.
    Am J Health Syst Pharm; 2011 Mar 01; 68(5):420-3. PubMed ID: 21330684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.